Certain Advertising Claims for FertilitySmart Conceive for Women Dietary Supplement Permanently Discontinued Following NAD Challenge

For Immediate Release
Contact: Abby Hills, Director of Communications, BBB National Programs

703.247.9330 / press@bbbnp.org

New York, NY – March 23, 2021 – FertilitySmart informed the National Advertising Division (NAD) of BBB National Programs that it has permanently discontinued all of the advertising claims for the company’s FertilitySmart Conceive for Women dietary supplement that were challenged by the Council for Responsible Nutrition (CRN).

The claims, which appeared in digital advertising, included:

  • “Helps Increase Egg Quality Released in Each Ovulatory Cycle.”
  • “Helps Boost Number of Eggs Released in Each Ovulatory Cycle.”
  • “Promotes Regular Ovulation.”
  • “Helps Maintain Healthy Uterine Lining.”   
  • “FertilitySmart Conceive for Women is recognized as a viable non-prescription option for women who are trying to get pregnant.  It encourages regular ovulation, supports regular menstrual cycles, and increases egg quality, without the risk of side effects associated with the drugs used in fertility treatment.”
  • “Try the only doctor-recommended fertility supplement today and start your journey towards success!”
  • “FertilitySmart Advance Fertility nutrition supplements are the only medical professional approved and recommended 100% natural fertility vitamins formulated specifically to increase both female and male fertility and improve overall reproductive health.”   

 

CRN also challenged several consumer testimonials relaying couples’ experiences with infertility and describing how the FertilitySmart product regulated ovulation and helped with conception even after failure with Clomid, IUI, IVF, and other medical interventions.

During the course of the proceeding, FertilitySmart informed NAD that instead of submitting substantiating evidence, it had permanently discontinued all of the challenged claims. In reliance on the advertiser’s representation, NAD did not review these claims on their merits.

In its advertiser statement, FertilitySmart stated that the challenged claims “had already been permanently discontinued before any NAD recommendations had been made.”

All BBB National Programs case decisions can be found in the case decision library. 

###

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.    

Latest Decisions

Decision

National Advertising Division Finds T-Mobile’s “Largest” 5G Network and Other Claims Supported; Recommends Certain Other Claims be Modified or Discontinued

New York, NY – October 20, 2021 – The National Advertising Division (NAD) determined that T-Mobile USA, Inc.’s claim to have the “largest” 5G network is substantiated and that its “5G speeds as fast as Wi-Fi” claim was supported in the context in which it was presented on the...

Read the Decision
Decision

National Advertising Review Board Recommends Johnson & Johnson Discontinue “#1 Dermatologist Recommended Skincare Brand” Claim for Neutrogena

New York, NY – October 20, 2021 – A panel of the National Advertising Review Board (NARB) has recommended that Johnson & Johnson Consumer Inc. (JJCI) discontinue the claim that its Neutrogena brand is the “#1 Dermatologist Recommended Skincare Brand.” 

Read the Decision
Decision

National Advertising Division Finds Certain Verizon 5G Claims Supported; Recommends Modification or Discontinuation of Others

New York, NY – October 19, 2021 – In the first National Advertising Division (NAD) Complex Track case, NAD determined that certain comparative performance claims for Verizon Wireless, Inc.’s 5G wireless service are supported or are non-actionable puffery. 
Read the Decision
Decision

National Advertising Review Board Finds Certain AT&T Comparative Advertising Claims Supported; Recommends Discontinuation or Modification of Others

New York, NY – October 14, 2021 – The National Advertising Review Board (NARB) has determined that AT&T Services, Inc. properly supported certain comparative advertising claims for its fiber-optic internet service in one commercial and one internet video advertisement. However, it...

Read the Decision